Pro-inflammatory cytokines and pain;Citocinas pró-inflamatórias e dor

Revista Brasileira de Reumatologia

Volumn 46, Issue 3, 2006, Pages 199-206

  Kraychete, Durval Campos ^a,b,d   Calasans, Maria Thais De Andrade ^b,c,d,e,f   Valente, Camila Motta Leal ^b,d,g  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b Hospital Universitário Professor Edgard Santos HUPES   (Brazil)

^c Escola de Enfermagem da UFBa

^d Dor ^*  (Brazil)

^e Grupo de Estudos Sobre a Saúde da Criança e do Adolescente CRESCER UFBa

^f SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^g Acadêmica da Escola de Enfermagem da UFBa

Author keywords

Cytokines; Neuroplasticity; Pain

Indexed keywords

CYTOKINE;

ASTROCYTE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; ENDOTHELIUM CELL; GLIA CELL; HUMAN; IMMUNOCOMPETENT CELL; MICROGLIA; NERVE CELL; NERVE CELL PLASTICITY; PAIN; REVIEW;

EID: 34249085032     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0482-50042006000300007     Document Type: Review

References (65)

1. Walters ET: Injury-related behavior and neuronal plasticity: An evolutionary perspective on sensitization, hyperalgesia and analgesia. Int Rev Neurobiol 36: 325-427, 1994.
2. Woolf CJ, Salter MW: Neuronal plasticity: Increasing the gain in pain. Science 288: 1765-9, 2000.
3. Wright A: Recent concepts in the neurophysiology of pain. Manual Therapy 4: 196-202, 1999.
4. Chuang HH, Prescott ED, Kong H et al: Bradykinin and nerve growth factor release the capsaicin receptor from ptdins(4,5)p2-mediated inhibition. Nature 411: 957-62, 2001.
5. Heppenstall PA, Lewin GR: Neurotrophins, nociceptors and pain. Curr Op Anaesthesiol 13: 573-6, 2000.
6. Ji RR, Kohno T, Moore KA, Woolf CJ: Central sensitization and ltp: Do pain and memory share similar mechanisms? Trends Neurosci 26: 696-705, 2003.
7. Lai J, Gold MS, Kim CS et al: Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, nav1.8. Pain 95: 143-52, 2002.
8. McMahon SB: Neuropathic pain mechanisms. In: Giamberardino MA (ed.), Pain 2002 - an updated rewiew: Refresher course syllabuss. IASP Press: Seattle, 155-161p., 2002.
9. Mannion RJ, Doubell TP, Coggeshall RE, Woolf CJ: Collateral sprouting of uninjured primary afferent a-fibers into the superficial dorsal horn of the adult rat spinal cord after topical capsaicin treatment to the sciatic nerve. J Neurosci 16: 5189-95, 1996.
10. Rowbotham MC, Fields HL: The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia. Brain 119: 347-54, 1996.
11. Choi B, Rowbotham MC: Effect of adrenergic receptor activation on post-herpetic neuralgia pain and sensory disturbances. Pain 69: 55-63, 1997.
12. Bennett GJ: Update on the neurophysiology of pain transmission and modulation: Focus on the nmda-receptor. J Pain Sympt Man 19: S2-6, 2000.
13. Li J, Simone DA, Larson AA: Windup leads to characteristics of central sensitization. Pain 79: 75-82, 1999.
14. Randic M, Jiang MC, Cerne R: Long-term potentiation and long-term depression of primary afferent neurotransmission in the rat spinal cord. J Neurosci 13: 5228-41, 1993.
15. Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ: P38 MAPk activation by ngf in primary sensory neurons after inflammation increases trpv1 levels and maintains heat hyperalgesia. Neuron 36: 57-68, 2002.
16. Sandkuhler J: Learning and memory in pain pathways. Pain 88: 113-8, 2000.
17. Hunt SP, Pini A, Evan G: Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 328: 632-4, 1987.
18. Jue DM, Jeon KI, Jeong JY: Nuclear factor kappab (NF-kappa b) pathway as a therapeutic target in rheumatoid arthritis. J Kor Med Sci 14: 231-8, 1999.
19. aed., IASP Press: Seattle, 3-7p., 2002.
20. Woolf CJ, Safieh-Garabedian B, Ma QP, Crilly P, Winter J: Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neurosci 62: 327-31, 1994.
21. Otten U, Goedert M, Mayer N, Lembeck F: Requirement of nerve growth factor for development of substance p-containing sensory neurones. Nature 287: 158-9, 1980.
22. Basbaum AI: Distinct neurochemical features of acute and persistent pain. Proc Nat Acad Scie (USA) 96: 7739-43, 1999.
23. Riedel W, Layka H, Neeck G: Secretory pattern of gh, tsh, thyroid hormones, acth, cortisol, fsh, and lh in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones. Rheumatology 57: 81-7, 1998.
24. Neeck G: Pathogenic mechanisms of fibromyalgia. Ag Res Review 1: 243-55, 2002.
25. Dessein PH, Shipton EA, Stanwix AE, Joffe BI: Neuroendocrine deficiency-mediated development and persistence of pain in fibromyalgia: A promising paradigm? Pain 86: 213-5, 2000.
26. Nelson PT, Soma LA, Lavi E: Microglia in diseases of the central nervous system. Ann Med 34: 491-500, 2002.
27. Rezaie P, Male D: Mesoglia & microglia - a historical review of the concept of mononuclear phagocytes within the central nervous system. J Histol Neurosci 11: 325-74, 2002.
28. DeLeo JA, Yezierski RP: The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90: 1-6, 2001.
29. Sheeran P, Hall GM: Cytokines in anaesthesia. Br J Anaesth 78: 201-19, 1997.
30. Clatworthy AL, Castro GA, Budelmann BU, Walters ET: Induction of a cellular defense reaction is accompanied by an increase in sensory neuron excitability in aplysia. J Neurosc 14: 3263-70, 1994.
31. Zipris D, Gilboa-Garber N: Stimulation of human peripheral lymphocytes and induction of interleukin 2 production by a lectin from the gonad of the sea hare, aplysia fasciata. Devel Compl Immunol 11: 501-11, 1987.
32. Weinreich D, Undem BJ: Immunological regulation of synaptic transmission in isolated guinea pig autonomic ganglia. J Clin Invest 79: 1529-32, 1987.
33. Wood JD: Communication between mimi-brain in gut and the enteric immune system. N Physioll Science 6: 64-9, 1991.
34. McDermott MF: TNF and TNFr biology in health and disease. Cell Mol Biol (Noisy-le-grand) 47: 619-35, 2001.
35. Schafers M, Svensson CI, Sommer C, Sorkin LS: Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 mapk in primary sensory neurons. J Neurosci 23: 2517-21, 2003.
36. Sommer C, Kress M: Recent findings on how proinflammatory cytokines cause pain: Peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neuroscien Letters 361: 184-7, 2004.
37. Sommer C, Petrausch S, Lindenlaub T, Toyka KV: Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy. Neuroscience Letters 270: 25-8, 1999.
38. Obreja O, Schmelz M, Poole S, Kress M: Interleukin-6 in combination with its soluble il-6 receptor sensitises rat skin nociceptors to heat, in vivo. Pain 96: 57-62, 2002.
39. Watkins LR, Wiertelak EP, Goehler LE, Smith KP, Martin D, Maier SF: Characterization of cytokine-induced hyperalgesia. Brain Research 654: 15-26, 1994.
40. Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S: Cytokines, nerve growth factor and inflammatory hyperalgesia: The contribution of tumour necrosis factor alpha. Br J Pharmacol 121: 417-24, 1997.
41. Junger H, Sorkin LS: Nociceptive and inflammatory effects of subcutaneous TNF. Pain 85: 145-51, 2000.
42. Wagner R, Myers RR: Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. Neuroreport 7: 2897-901, 1996.
43. Sorkin LS, Xiao WH, Wagner R, Myers RR: Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 81: 255-62, 1997.
44. Shubayev VI, Myers RR: Axonal transport of tnf-alpha in painful neuropathy: Distribution of ligand tracer and tnf receptors. J Neuroimmunol 114: 48-56, 2001.
45. Ferreira SH, Lorenzetti BB, Cunha FQ, Poole S: Bradykinin release of tnf-alpha plays a key role in the development of inflammatory hyperalgesia. Agents Actions 38: C7-9, 1993.
46. Cunha FQ, Lorenzetti BB, Poole S, Ferreira SH: Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol 104: 765-7, 1991.
47. Meller ST, Dykstra C, Grzybycki D, Murphy S, Gebhart GF: The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology 33: 1471-8, 1994.
48. Heinrich PC, Castell JV, Andus T: Interleukin-6 and the acute phase response. Biochem J 265: 621-36, 1990.
49. Watkins LR, Maier SF, Goehler LE: Cytokine-to-brain communication: A review & analysis of alternative mechanisms. Life Sci 57:1011-26, 1995.
50. Watkins LR, Maier SF, Goehler LE: Immune activation: The role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63: 289-302, 1995.
51. Ericsson A, Kovacs KJ, Sawchenko PE: A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 14: 897-913, 1994.
52. Banks WA, Kastin AJ: Saturable transport of peptides across the blood-brain barrier. Life Science 41: 1319-38, 1987.
53. Fleshner M, Goehler LE, Hermann J, Relton JK, Maier SF, Watkins LR: Interleukin-1 beta induced corticosterone elevation and hypothalamic ne depletion is vagally mediated. Brain Res Bull 37: 605-10, 1995.
54. Goehler LE, Busch CR, Tartaglia N, et al: Blockade of cytokine induced conditioned taste aversion by subdiaphragmatic vagotomy: Further evidence for vagal mediation of immune-brain communication. Neurosci Lett 185: 163-6, 1995.
55. Thompson ME, Barkhuizen A: Fibromyalgia, hepatitis c infection, and the cytokine connection. Curr PainHeadache Rep 7: 342-7, 2003.
56. Arruda JL, Colburn RW, Rickman AJ, Rutkowski MD, DeLeo JA: Increase of interleukin-6 mrna in the spinal cord following peripheral nerve injury in the rat: Potential role of il-6 in neuropathic pain. Brain Res: Mol Brain Res 62: 228-35, 1998.
57. Okamoto K, Martin DP, Schmelzer JD, Mitsui Y, Low PA: Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp Neurol 169: 386-91, 2001.
58. Cui JG, Holmin S, Mathiesen T, Meyerson BA, Linderoth B: Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain 88: 239-48, 2000.
59. Homma Y, Brull SJ, Zhang JM. A comparison of chronic pain behavior following local application of tumor necrosis factor alpha to the normal and mechanically compressed lumbar ganglia in the rat. Pain 95: 239-46, 2002.
60. Winkelstein BA, Rutkowski MD, Weinstein JN, DeLeo JA. Quantification of neural tissue injury in a rat radiculopathy model: Comparison of local deformation, behavioral outcomes, and spinal cytokine mrna for two surgeons. J Neurosci Meth 111: 49-57, 2001.
61. Burke JG, Watson RW, McCormack D, Dowling FE, Walsh MG, Fitzpatrick JM: Spontaneous production of monocyte chemoattractant protein-1 and interleukin-8 by the human lumbar intervertebral disc. Spine 27: 1402-7, 2002.
62. Omarker K, Myers RR: Pathogenesis of sciatic pain: Role of herniated nucleus pulposus and deformation of spinal nerve root and dorsal root ganglion. Pain 78: 99-105, 1998.
63. Specchia N, Pagnotta A, Toesca A, Greco F: Cytokines and growth factors in the protruded intervertebral disc of the lumbar spine. Eur Spine J 11: 145-51, 2002.
64. Brisby H, Olmarker K, Larsson K, Nutu M, Rydevik B: Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica. Eur Spine J 11: 62-6, 2002.
65. Geiss A, Varadi E, Steinbach K, Bauer HW, Anton F: Psychoneuroimmunological correlates of persisting sciatic pain in patients who underwent discectomy. Neurosci Lett 237: 65-8, 1997.